Research progress on screening methods for early prostate cancer.
- Author:
Mei-Hui ZHANG
1
;
Hua CHENG
1
;
Hao-Yong NING
1
Author Information
1. Department of Pathology, Hainan Hospital of the PLA General Hospital, Sanya, Hainan 572013, China.
- Publication Type:English Abstract
- Keywords:
prostate cancer;
prostate specific antigen;
prostate biopsy;
non-coding RNA;
early screening
- MeSH:
Humans;
Male;
Prostatic Neoplasms/diagnosis*;
Early Detection of Cancer/methods*;
Prostate-Specific Antigen/blood*
- From:
National Journal of Andrology
2025;31(8):737-741
- CountryChina
- Language:Chinese
-
Abstract:
Prostate cancer is a common malignant tumor of the male urinary system. Early diagnosis is very important to improve the survival rate and quality of life of patients. In this paper, the screening methods for early prostate cancer will be systematically reviewed, covering serum prostate-specific antigen (PSA) related testing, non-PSA related testing, as well as emerging genetic and genetic testing technologies. The principle, advantages and limitations of each screening method will be briefly analyzed as well. In order to avoid excessive puncture biopsy, a basis for reasonable clinical screening strategy for prostate cancer will be introduced, so as to realize early detection, diagnosis and treatment of disease and improve the prognosis of patients.
